Cartalax 20mg (Bioregulator)

Cartalax 20mg is a premium, high-purity synthetic short-chain bioregulatory tripeptide available exclusively at The Peptide Store for advanced laboratory research. Formulated to ≥98% purity and rigorously verified by HPLC and mass spectrometry, this compound serves as a precision biochemical tool for investigating connective tissue biology, cartilage extracellular matrix dynamics, and fibroblast proliferation mechanisms. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Cartalax is a member of the cytogen class of short-chain bioregulatory peptides, structurally derived from natural peptide fragments identified endogenously within mammalian cartilage and connective tissues. Researchers investigating gene expression regulation, collagen synthesis pathways, and age-associated cellular senescence will find this compound an exceptionally precise molecular probe. The Peptide Store offers Cartalax in a 20mg configuration, providing sufficient material for multi-stage experimental protocols within controlled laboratory environments.

Peptide Structure & Amino Acid Sequence

Cartalax is biochemically classified as a synthetic tripeptide with the amino acid sequence L-Alanyl-L-Glutamyl-L-Aspartic Acid (Ala-Glu-Asp). This ultra-short three-residue chain confers an exceptionally low molecular weight, enabling the peptide to traverse cellular membranes with minimal steric resistance and access the nuclear compartment directly. This structural characteristic positions Cartalax as a direct epigenetic modulator, capable of interacting with chromatin-associated regulatory elements to influence the transcription of key structural proteins including collagen and proteoglycans central to cartilage matrix integrity.

Chemical & Physical Characteristics

• Peptide Sequence: Ala-Glu-Asp (L-Alanyl-L-Glutamyl-L-Aspartic Acid)
• Peptide Class: Cytogen-class short-chain bioregulatory tripeptide
• Molecular Formula: C₁₂H₁₉N₃O₈
• Molecular Weight: Approximately 337.3 g/mol
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffer systems under standard laboratory conditions
• Purity: ≥98% by HPLC analysis
• Storage Stability: Stable under recommended laboratory cold-chain storage conditions

Purity & Analytical Verification (HPLC & MS)

Every batch of Cartalax supplied by The Peptide Store undergoes rigorous analytical testing prior to release. High-Performance Liquid Chromatography (HPLC) is used to confirm a minimum purity threshold of ≥98%, while mass spectrometry (MS) validates the correct molecular identity and sequence fidelity of the tripeptide. Certificates of Analysis (CoA) reflecting these analytical results are available upon request, ensuring complete traceability and batch-level quality assurance for all research applications.

Quality Control & Lyophilization Integrity

Cartalax is supplied in lyophilized powder form, a preservation method that removes residual moisture through controlled freeze-drying, thereby maximizing long-term structural stability and minimizing peptide degradation. Each production lot is subject to strict quality control protocols encompassing identity confirmation, purity assessment, and physical inspection of the lyophilized cake. This multi-stage QC framework ensures researchers receive a compound of consistent quality suitable for reproducible experimental outcomes.

Safety, Handling & Laboratory Precautions

Cartalax is intended exclusively for in vitro and ex vivo research applications conducted by trained laboratory professionals. Standard laboratory personal protective equipment (PPE) including gloves, lab coat, and appropriate eye protection should be worn during all handling procedures. This compound must not be administered to humans or animals under any circumstances. Researchers should consult applicable institutional biosafety guidelines and local regulatory frameworks when working with synthetic peptide compounds.

Reconstitution, Packaging & Storage

Cartalax arrives as a lyophilized powder sealed in a sterile vial appropriate for laboratory research use. For optimal stability, the lyophilized product should be stored at −20°C in a dry, dark environment, protected from repeated freeze-thaw cycles. Reconstitution should be performed using appropriate aqueous laboratory solvents in accordance with the specific requirements of the intended research protocol. Once reconstituted, solutions should be aliquoted and stored under conditions consistent with institutional cold-chain standards. All reconstitution procedures are strictly for in vitro research use only.

Intended Research Use & Market Positioning

Cartalax is positioned as a high-value research tool for academic institutions, pharmaceutical research organizations, and biotechnology laboratories engaged in the study of connective tissue biology, musculoskeletal aging, epigenetic regulation of structural protein expression, and regenerative dermatology models. Its ultra-low molecular weight and direct nuclear accessibility make it particularly valuable for researchers seeking to elucidate mechanisms underlying cartilage matrix remodeling and fibroblast-mediated tissue repair at the molecular level.

Ordering, Availability & Fulfillment

The Peptide Store offers Cartalax for sale online with streamlined ordering, competitive best-price positioning, and reliable global fulfillment. Researchers can order now through our secure eCommerce platform with confidence in batch-specific purity documentation and professional-grade packaging. Our logistics infrastructure supports prompt dispatch and cold-chain-compatible shipping to qualified research institutions worldwide. Contact our team for bulk order inquiries or custom configurations.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Cartalax is sold exclusively as a laboratory research reagent. The Peptide Store assumes no liability for misuse, improper handling, or application of this compound outside of its intended in vitro research context. Purchasers are solely responsible for ensuring compliance with all applicable national, regional, and institutional regulations governing the acquisition, storage, and use of synthetic peptide research compounds. This product is not a drug, supplement, or therapeutic agent and has not been evaluated or approved by any regulatory authority for use in humans or animals.